Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableStudy completedNCT00001320
What this trial is testing

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Who this might be right for
HealthySchizophrenia
National Institute of Mental Health (NIMH) 265
Not applicableStudy completedNCT00004826
What this trial is testing

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Memorial Hospital of Rhode Island 60
Testing effectiveness (Phase 2)Study completedNCT01518309
What this trial is testing

An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 39
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Testing effectiveness (Phase 2)WithdrawnNCT05344365
What this trial is testing

Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Vanda Pharmaceuticals
Not applicableEnded earlyNCT03152292
What this trial is testing

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 764
Testing effectiveness (Phase 2)Study completedNCT00087542
What this trial is testing

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Who this might be right for
HallucinationsPsychosesParkinson's Disease
ACADIA Pharmaceuticals Inc. 60
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Large-scale testing (Phase 3)Study completedNCT06068465
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
Tasly Pharmaceutical Group Co., Ltd 248
Post-approval studies (Phase 4)Study completedNCT04292223
What this trial is testing

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 29
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300